Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Minority Interest: 2016-2021

Historic Minority Interest for Myriad Genetics (MYGN) over the last 1 years, with Sep 2021 value amounting to -$100,000.

  • Myriad Genetics' Minority Interest was N/A to -$100,000 in Q3 2021 from the same period last year, while for Sep 2021 it was -$100,000, marking a year-over-year change of. This contributed to the annual value of -$400,000 for FY2017, which is N/A change from last year.
  • Per Myriad Genetics' latest filing, its Minority Interest stood at -$100,000 for Q3 2021, which was down 0.00% from -$100,000 recorded in Q2 2021.
  • Over the past 5 years, Myriad Genetics' Minority Interest peaked at $100,000 during Q1 2018, and registered a low of -$400,000 during Q2 2017.
  • In the last 2 years, Myriad Genetics' Minority Interest had a median value of -$100,000 in 2021 and averaged -$50,000.
  • Examining YoY changes over the last 5 years, Myriad Genetics' Minority Interest showed a top increase of 200.00% in 2019 and a maximum decrease of 200.00% in 2019.
  • Over the past 4 years, Myriad Genetics' Minority Interest (Quarterly) stood at -$300,000 in 2017, then spiked by 133.33% to -$100,000 in 2018, then spiked by 200.00% to $100,000 in 2019, then reached -$100,000 in 2021.
  • Its Minority Interest stands at -$100,000 for Q3 2021, versus -$100,000 for Q2 2021 and $100,000 for Q4 2019.